Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of Radiation Therapy Oncology Group 93-05 protocol
Luís Souhami(McGill University Health Centre), Walter J. Curran(Piedmont Cancer Institute), Wendy Seiferheld(RTOG Foundation), Robert A. Lustig(University of Pennsylvania), Jan C. Buckner(McGill University), Minesh P. Mehta(Columbia University), Paul Okunieff(Unknown), Maria Werner‐Wasik(American College of Radiology), David Brachman(Barrow Neurological Institute), Ervin B. Podgoršak(McGill University), Christopher J. Schultz(Medical College of Wisconsin), Lucía Zamorano(Wayne State University), William T. Sause(LDS Hospital)
International Journal of Radiation Oncology*Biology*Physics
October 5, 2004
Cited by 564
Related Papers
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
|Journal of Clinical Oncology|2000|2.3k
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05
|International Journal of Radiation Oncology*Biology*Physics|2000|1.6k